New Angi Report Finds Nearly 90% of Skilled Tradespeople Satisfied in Their Careers
DENVER, May 21, 2024 (GLOBE NEWSWIRE) — Angi, a leading and comprehensive solution for improving and maintaining homes, today released […]
United Maritime Announces the Date for the First Quarter Ended March 31, 2024, Financial Results
GLYFADA, Greece, May 21, 2024 (GLOBE NEWSWIRE) — United Maritime Corporation (the “Company” or “United”) (NASDAQ: USEA), announced today that […]
Safe and Green Development Corporation increases sales price of St Mary’s to $1.4M
MIAMI, Fla, May 21, 2024 (GLOBE NEWSWIRE) — Safe and Green Development Corporation (NASDAQ: SGD) (“SG DevCo” or the “Company”) […]
U.S. Realty Advisors selects Intapp to empower firm growth with AI
PALO ALTO, Calif., May 21, 2024 (GLOBE NEWSWIRE) — Intapp (NASDAQ: INTA), a leading global provider of AI-powered solutions for […]
Xylo Technologies Signs LOI to Acquire a Leading AI Technology Company Based in Germany
TEL AVIV, Israel, May 21, 2024 (GLOBE NEWSWIRE) — Xylo Technologies Ltd. (Nasdaq: XYLO) (“Xylo” or the “Company”), a technology-based […]
LPL Financial Welcomes Auctus Legacy Private Wealth Management
SAN DIEGO, May 21, 2024 (GLOBE NEWSWIRE) — LPL Financial LLC announced today that financial advisors Alain Verhille, CFP®, CPFA®, […]
Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
BOSTON and LONDON, May 21, 2024 (GLOBE NEWSWIRE) — Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims […]
Alpha Tau to Present at the Jefferies Global Healthcare Conference
JERUSALEM, May 21, 2024 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (“Alpha Tau”, or the “Company”) (NASDAQ: DRTS, DRTSW), the […]
Silo Pharma Announces Positive Results from Study for Depression Treatment, Remission, and Relapse Prevention
The study has identified a potentially new drug formulation that could potentially extend the period of remission and prevent relapse […]
GRI Bio Presents Positive Preclinical Data from Pipeline of NKT Cell Modulators in Development for the Treatment of Systemic Lupus Erythematosus (SLE)
Data presented at the 14thInternational Congress on Autoimmunity Encouraging preclinical data observed to date on par with OFEV®(nintedanib),a leading tyrosine […]
